Siemens Japanese Subsidiary Launches New Immunoassy System
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based Siemens Healthcare Diagnostics launched Immulite 2000 XPi immunoassay in Japan. The device is used to detect onset of diseases by identifying and analyzing certain proteins from blood samples. The device requires a very small amount of specimen and also needs less maneuvering. Priced at ¥25 million, the device is marketed by the Japanese subsidiary of Siemens medical device and diagnostics unit. (Click here for more - Japanese language)"Siemens Immunoassy System Uses Less Specimen And Easy To Operate" - Nikkei Sangyo News (1/29/2010)
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.